SELINEXOR

SELINEXOR (13085Q)

selinexor 20 mg tablet, 16
13085Q
Body System:
Manner of administration:Oral
Public
S100 HSD Public
Authority Required

Restriction

Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Initial treatment - Dose requirement of 80 mg, 60 mg or 40 mg per week

Restriction

Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Continuing treatment - Dose requirement of 80 mg, 60 mg or 40 mg per week
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 16 # of repeats: 2 DPMQ: $9,360.00 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Xpovio

SELINEXOR (13099K)

selinexor 20 mg tablet, 16
13099K
Body System:
Manner of administration:Oral
Private
S100 HSD Private
Authority Required

Restriction

Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Initial treatment - Dose requirement of 80 mg, 60 mg or 40 mg per week

Restriction

Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Continuing treatment - Dose requirement of 80 mg, 60 mg or 40 mg per week
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 16 # of repeats: 2 DPMQ: $9,408.88 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Xpovio